Vivos Therapeutics Inc (VVOS) — Defensive Interval Ratio
Vivos Therapeutics Inc (VVOS) has a Defensive Interval Ratio of 32 days as of March 2026. Defensive assets of $1.58 Million (cash $-, short-term investments $-, receivables $1.58 Million) cover 32 days of daily cash needs of $49.52K/day. Check how tangible is Vivos Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Vivos Therapeutics Inc Defensive Interval Ratio (2018–2025)
This chart shows how Vivos Therapeutics Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 32 days, meaning defensive assets of $1.58 Million can fund 32 days of operations without new revenue. Also explore net asset momentum of Vivos Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Vivos Therapeutics Inc (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Vivos Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see VVOS market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 32 days | $1.58 Million | $49.52K/day | $- | $- | ▲ +0 days |
| 2024 | 32 days | $430.00K | $13.64K/day | $- | $- | ▲ +21 days |
| 2023 | 10 days | $202.00K | $19.97K/day | $- | $- | ▼ -14 days |
| 2022 | 24 days | $457.00K | $18.67K/day | $- | $- | ▼ -59 days |
| 2021 | 84 days | $1.72 Million | $20.57K/day | $- | $- | ▲ +13 days |
| 2020 | 71 days | $1.52 Million | $21.43K/day | $- | $- | ▲ +32 days |
| 2019 | 38 days | $955.99K | $24.91K/day | $- | $- | ▼ -62 days |
| 2018 | 101 days | $595.19K | $5.91K/day | $- | $- | — |